YOLFTbeta
Atomo Diagnostics Ltd

Atomo Diagnostics Ltd

AT1 · AU · Healthcare / Medical Devices

0.012AUD+0.00 (0.00%)

Price History

Full chart

Market Stats

Previous Close0.012
Open0.012
Day Range0.012 – 0.013
52-Week Range0.016 – 0.048
Volume6.65M
Market Cap15.34M
P/E (TTM)0.00
Forward P/E84.75
EPS0.00
Dividend Yield0.00%
Beta1.11
50-Day Avg0.0178
200-Day Avg0.0262

About

Atomo Diagnostics Limited engages in the development and sale of medical devices worldwide. The company offers blood test devices, such as Pascal, Curie, Galileo, Elion, and Florey under the AtomoRapid brand. It also offers HIV Rapid self-testing programs; and digital health solutions. Atomo Diagnostics Limited was incorporated in 2010 and is headquartered in Leichhardt, Australia.

Company Details

  • SectorHealthcare
  • IndustryMedical Devices
  • CEODr. Cheri L. Walker Ph.D.
  • Employees0
  • Headquarters3-5 George Street, Leichhardt, NSW, Australia, 2040, Australia
  • Websitehttps://atomodiagnostics.com

Leadership

  • Dr. Cheri L. Walker Ph.D.Interim CEO & Director
  • Ms. Chandra SukumarChief Operating Officer
  • Mr. Mathew Leslie Watkins C.A.Company Secretary

Financials

Income Statement

Currency: AUD2017-06-302018-06-302019-06-302020-06-302021-06-302022-06-302023-06-302024-06-302025-06-302026-06-30
Total Revenue294.93K287.25K539.74K5.37M6.72M12.34M2.54M4.09M3.79M5.33M
Growth (%)--2.60%+87.90%+894.69%+25.09%+83.69%-79.38%+60.65%-7.20%+40.65%
Cost of Revenue2.60M2.35M3.11M5.83M8.43M14.19M8.62M2.65M2.00M7.76M
Gross Profit-2.31M-2.06M-2.57M-464.83K-1.71M-1.85M-6.08M1.44M1.79M-2.43M
Gross Margin-782.04%-716.88%-475.90%-8.66%-25.50%-15.03%-238.93%35.16%47.28%-45.56%
Operating Expense5.18M4.54M2.94M3.12M4.46M6.25M3.96M8.60M5.60M3.26M
Operating Income-7.49M-6.59M-5.51M-3.58M-6.18M-8.11M-10.04M-7.16M-3.81M-5.69M
Operating Margin-2540.04%-2295.76%-1020.27%-66.74%-91.98%-65.72%-394.66%-175.23%-100.50%-106.65%
EBITDA-4.53M-5.78M-4.86M-4.05M-4.70M-4.72M-9.00M-6.12M-4.69M-4.26M
EBITDA Margin-1536.84%-2010.50%-901.02%-75.49%-69.91%-38.29%-353.71%-149.71%-123.79%-79.86%
Net Income-5.15M-4.90M-5.06M-9.22M-6.02M-5.71M-9.96M-6.85M-4.97M-3.51M
Net Income Margin-1745.65%-1705.89%-936.59%-171.70%-89.66%-46.26%-391.46%-167.57%-131.08%-65.87%
R&D3.21M2.88M1.34M695.01K820.64K1.41M604.72K236.42K881.60K758.12K
R&D as % of Total Revenue1087.65%1002.21%247.45%12.95%12.22%11.44%23.77%5.79%23.25%14.21%
Interest Expense1.63M1.10M436.94K5.29M7.79K15.47K14.99K9.52K16.69K14.74K
Interest Expense % of Total Revenue551.60%381.47%80.95%98.44%0.12%0.13%0.59%0.23%0.44%0.28%

Balance Sheet

Currency: AUD2017-06-302018-06-302019-06-302020-06-302021-06-302022-06-302023-06-302024-06-302025-06-302026-06-30
Total Assets11.87M7.76M6.05M36.10M32.24M26.62M16.47M11.38M9.28M10.83M
Total Liabilities11.82M12.64M11.52M1.62M2.15M1.81M1.68M1.29M2.30M3.12M
Total Equity47.82K-4.89M-5.47M34.48M30.09M24.81M14.79M10.08M6.98M7.71M
Cash8.28M1.99M1.86M27.10M17.95M12.97M6.47M3.69M3.22M3.71M
Total Debt10.96M11.49M10.34M55.55K67.59K340.81K254.88K141.19K185.10K373.08K
Net Debt2.69M9.50M8.48M-27.05M-17.88M-12.63M-6.22M-3.55M-3.03M-3.34M

Cash Flow

Currency: AUD2017-06-302018-06-302019-06-302020-06-302021-06-302022-06-302023-06-302024-06-302025-06-302026-06-30
Operating Cash Flow-5.26M-5.56M-1.84M-6.26M-4.23M-2.81M-5.85M-4.69M-1.96M-3.37M
Investing Cash Flow-606.48K-642.63K-813.36K-1.99M-5.90M-2.31M-401.28K-16.08K-33.89K-35.32K
Financing Cash Flow7.28M12.43M33.61M997.37K17.61K-170.75K1.87M1.46M3.81M
Capital Expenditure606.48K642.63K813.36K1.99M5.90M2.31M401.28K16.08K33.89K35.33K
Free Cash Flow-5.86M-6.20M-2.65M-8.26M-10.12M-5.11M-6.25M-4.70M-1.99M-3.40M
FCF to OCF111.54%111.56%144.24%131.83%239.58%182.14%106.86%100.34%101.73%101.05%

Earnings

Report DateApr 14, 2020Aug 30, 2020Feb 22, 2021Jun 2, 2021Aug 26, 2021Oct 25, 2021Feb 21, 2022Jun 1, 2022Sep 22, 2022Oct 25, 2022Feb 23, 2023Apr 27, 2023Aug 23, 2023Oct 23, 2023Feb 25, 2024May 29, 2024Aug 29, 2024Oct 28, 2024Feb 27, 2025Apr 24, 2025Aug 28, 2025Nov 28, 2025Apr 23, 2026
EPS Estimate0.000.000.000.00-0.000.000.00-0.00-0.000.000.000.000.000.000.000.000.000.000.000.00
EPS Actual-0.01-0.010.000.00-0.010.000.000.00-0.010.00-0.010.000.000.000.000.000.000.000.000.000.000.000.00
Surprise-----------------------
TimingPre-marketAfter-hoursAfter-hours-After-hours-Pre-market-After-hoursAfter-hoursAfter-hoursPre-marketAfter-hours----------

Key Statistics & Ratios

Market Cap15.34M
Enterprise Value13.36M
Trailing P/E0.00
Forward P/E84.75
Price / Sales2.93
Price / Book2.17
EPS0.00
Book Value0.009
Revenue (TTM)5.33M
Gross Profit (TTM)1.76M
EBITDA-4.09M
Profit Margin-65.87%
Operating Margin-82.07%
Return on Equity-47.86%
Return on Assets-31.24%
Shares Outstanding902.43M
Shares Float513.76M
Beta1.11
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%